Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Nov;3(6):740–745. doi: 10.1128/cdli.3.6.740-745.1996

Production of T-helper cell subsets and cytokines by lymphocytes from patients with chronic mucocutaneous candidiasis.

L J Kobrynski 1, L Tanimune 1, L Kilpatrick 1, D E Campbell 1, S D Douglas 1
PMCID: PMC170440  PMID: 8914768

Abstract

Chronic mucocutaneous candidiasis (CMC) is a heterogeneous group of disorders characterized by recurrent and persistent superficial candidal infections. Cytokine-induced dysregulation of T-helper cell function has been described in other immune-deficient states but has not been studied in CMC patients. We studied T-helper cell subsets by flow cytometry and cytokine production by stimulated lymphocytes in six CMC patients, two healthy pediatric controls, and five healthy adult controls. Peripheral blood lymphocytes were stimulated in vitro with phytohemagglutinin or Candida albicans extract, and the production of interleukin-2R (IL-2R), IL-4, IL-10, and gamma interferon in the supernatants was measured by enzyme-linked immunosorbent assay. CMC patients had a decrease in the CD29+/CD29+ cell population compared with the numbers in controls (P < 0.02). The percentage of CD4+/CD45RA+ cells was greater in patients than in controls, but the difference was not significant. There was no difference in the production of IL-10 or gamma interferon by the patient lymphocytes. CMC patients produced more IL-4 than the controls (P < 0.001), whereas the controls tended to produce more IL-2R than the patients (P = 0.19). These findings support the concept that a decrease in CD4+/CD29+ T-helper inducer cells along with T-helper cell dysregulation may lead to defective memory responses to antigens in CMC patients and a decrease in cell-mediated immunity due to inhibition of TH1 cells by increased levels of IL-4.

Full Text

The Full Text of this article is available as a PDF (218.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akbar A. N., Terry L., Timms A., Beverley P. C., Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol. 1988 Apr 1;140(7):2171–2178. [PubMed] [Google Scholar]
  2. Becker H., Langrock A., Federlin K. Imbalance of CD4+ lymphocyte subsets in patients with mixed connective tissue disease. Clin Exp Immunol. 1992 Apr;88(1):91–95. doi: 10.1111/j.1365-2249.1992.tb03044.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bettens F., Walker C., Gauchat J. F., Gauchat D., Wyss T., Pichler W. J. Lymphokine gene expression related to CD4 T cell subset (CD45R/CDw29) phenotype conversion. Eur J Immunol. 1989 Sep;19(9):1569–1574. doi: 10.1002/eji.1830190908. [DOI] [PubMed] [Google Scholar]
  4. Byrne J. A., Butler J. L., Cooper M. D. Differential activation requirements for virgin and memory T cells. J Immunol. 1988 Nov 15;141(10):3249–3257. [PubMed] [Google Scholar]
  5. Chilgren R. A., Meuwissen H. J., Quie P. G., Good R. A., Hong R. The cellular immune defect in chronic mucocutaneous candidiasis. Lancet. 1969 Jun 28;1(7609):1286–1288. doi: 10.1016/s0140-6736(69)92223-5. [DOI] [PubMed] [Google Scholar]
  6. Clerici M., Hakim F. T., Venzon D. J., Blatt S., Hendrix C. W., Wynn T. A., Shearer G. M. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest. 1993 Mar;91(3):759–765. doi: 10.1172/JCI116294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clerici M., Wynn T. A., Berzofsky J. A., Blatt S. P., Hendrix C. W., Sher A., Coffman R. L., Shearer G. M. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest. 1994 Feb;93(2):768–775. doi: 10.1172/JCI117031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crockard A. D., Boyd N. A., McNeill T. A., McCluskey D. R. CD4 lymphocyte subset abnormalities associated with impaired delayed cutaneous hypersensitivity reactions in patients with X-linked agammaglobulinaemia. Clin Exp Immunol. 1992 Apr;88(1):29–34. doi: 10.1111/j.1365-2249.1992.tb03034.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Durandy A., Fischer A., Le Deist F., Drouhet E., Griscelli C. Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J Clin Immunol. 1987 Sep;7(5):400–409. doi: 10.1007/BF00917018. [DOI] [PubMed] [Google Scholar]
  10. Dwyer J. M. Chronic mucocutaneous candidiasis. Annu Rev Med. 1981;32:491–497. doi: 10.1146/annurev.me.32.020181.002423. [DOI] [PubMed] [Google Scholar]
  11. Erard F., Wild M. T., Garcia-Sanz J. A., Le Gros G. Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. Science. 1993 Jun 18;260(5115):1802–1805. doi: 10.1126/science.8511588. [DOI] [PubMed] [Google Scholar]
  12. Flynn P. M., Barrett F. F., Herrod H. G. Disseminated histoplasmosis in two patients with chronic mucocutaneous candidiasis. Pediatr Infect Dis J. 1987 Jul;6(7):691–693. doi: 10.1097/00006454-198707000-00018. [DOI] [PubMed] [Google Scholar]
  13. Herrod H. G. Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group. J Pediatr. 1990 Mar;116(3):377–382. doi: 10.1016/s0022-3476(05)82824-0. [DOI] [PubMed] [Google Scholar]
  14. Kauffman C. A., Shea M. J., Frame P. T. Invasive fungal infections in patients with chronic mucocutaneous candidiasis. Arch Intern Med. 1981 Jul;141(8):1076–1079. [PubMed] [Google Scholar]
  15. Kirkpatrick C. H. Chronic mucocutaneous candidiasis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):448–456. doi: 10.1007/BF01964059. [DOI] [PubMed] [Google Scholar]
  16. Kuruganti U., Henderson L. A., Garner R. E., Asofsky R., Baker P. J., Domer J. E. Nonspecific and Candida-specific immune responses in mice suppressed by chronic administration of anti-mu. J Leukoc Biol. 1988 Nov;44(5):422–433. doi: 10.1002/jlb.44.5.422. [DOI] [PubMed] [Google Scholar]
  17. Lebranchu Y., Thibault G., Degenne D., Bardos P. Deficiency of CD4+CD45R+ T lymphocytes in common variable immunodeficiency. N Engl J Med. 1990 Jul 26;323(4):276–277. doi: 10.1056/NEJM199007263230416. [DOI] [PubMed] [Google Scholar]
  18. Matsuyama T., Yamada A., Rothstein D. M., Anderson K. C., Schlossman S. F., Morimoto C. CD45 isoforms associated with distinct functions of CD4 cells derived from unusual healthy donors lacking CD45RA- T lymphocytes. Cell Immunol. 1991 Oct 15;137(2):406–419. doi: 10.1016/0008-8749(91)90089-t. [DOI] [PubMed] [Google Scholar]
  19. Morimoto C., Letvin N. L., Boyd A. W., Hagan M., Brown H. M., Kornacki M. M., Schlossman S. F. The isolation and characterization of the human helper inducer T cell subset. J Immunol. 1985 Jun;134(6):3762–3769. [PubMed] [Google Scholar]
  20. Oyefara B. I., Kim H. C., Danziger R. N., Carroll M., Greene J. M., Douglas S. D. Autoimmune hemolytic anemia in chronic mucocutaneous candidiasis. Clin Diagn Lab Immunol. 1994 Jan;1(1):38–43. doi: 10.1128/cdli.1.1.38-43.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Paganelli R., Scala E., Scarselli E., Ortolani C., Cossarizza A., Carmini D., Aiuti F., Fiorilli M. Selective deficiency of CD4+/CD45RA+ lymphocytes in patients with ataxia-telangiectasia. J Clin Immunol. 1992 Mar;12(2):84–91. doi: 10.1007/BF00918137. [DOI] [PubMed] [Google Scholar]
  22. Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Conceiço-Silva F., Modlin R. L. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest. 1993 Apr;91(4):1390–1395. doi: 10.1172/JCI116341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Porrini A. M., Gambi D., Malatesta G. Memory and naive CD4+ lymphocytes in multiple sclerosis. J Neurol. 1992 Oct;239(8):437–440. doi: 10.1007/BF00856808. [DOI] [PubMed] [Google Scholar]
  24. Richards S. J., Scott C. S., Cole J. C., Gooi H. C. Abnormal CD45R expression in patients with common variable immunodeficiency and X-linked agammaglobulinaemia. Br J Haematol. 1992 Jun;81(2):160–166. doi: 10.1111/j.1365-2141.1992.tb08201.x. [DOI] [PubMed] [Google Scholar]
  25. Salgame P., Abrams J. S., Clayberger C., Goldstein H., Convit J., Modlin R. L., Bloom B. R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 1991 Oct 11;254(5029):279–282. doi: 10.1126/science.254.5029.279. [DOI] [PubMed] [Google Scholar]
  26. Sanders M. E., Makgoba M. W., Sharrow S. O., Stephany D., Springer T. A., Young H. A., Shaw S. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol. 1988 Mar 1;140(5):1401–1407. [PubMed] [Google Scholar]
  27. Sanders M. E., Makgoba M. W., Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today. 1988 Jul-Aug;9(7-8):195–199. doi: 10.1016/0167-5699(88)91212-1. [DOI] [PubMed] [Google Scholar]
  28. Schauer U., Jung T., Heymanns J., Rieger C. H. Imbalance of CD4+CD45R+ and CD4+CD29+ T helper cell subsets in patients with atopic diseases. Clin Exp Immunol. 1991 Jan;83(1):25–29. doi: 10.1111/j.1365-2249.1991.tb05582.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shimizu Y., Shaw S., Graber N., Gopal T. V., Horgan K. J., Van Seventer G. A., Newman W. Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature. 1991 Feb 28;349(6312):799–802. doi: 10.1038/349799a0. [DOI] [PubMed] [Google Scholar]
  30. Swain S. L., Bradley L. M., Croft M., Tonkonogy S., Atkins G., Weinberg A. D., Duncan D. D., Hedrick S. M., Dutton R. W., Huston G. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev. 1991 Oct;123:115–144. doi: 10.1111/j.1600-065x.1991.tb00608.x. [DOI] [PubMed] [Google Scholar]
  31. Swain S. L., Huston G., Tonkonogy S., Weinberg A. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol. 1991 Nov 1;147(9):2991–3000. [PubMed] [Google Scholar]
  32. Twomey J. J., Waddell C. C., Krantz S., O'reilly R., L'esperance P., Good R. A. Chronic mucocutaneous candidiasis with macrophage dysfunction, a plasma inhibitor, and co-existent aplastic anemia. J Lab Clin Med. 1975 Jun;85(6):968–977. [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES